Back to 
BlackRock Finance, Inc.
BlackRock Finance, Inc.
FDMT3 quarters
Position history for BlackRock Finance, Inc.'s holdings in 4D MOLECULAR THERAPEUTICS IN
BlackRock Finance, Inc. holds 4.9M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $102.8M as of 2024-Q2. The position was increased (+14.3% shares). FDMT represents 0.0% of BlackRock Finance, Inc.'s portfolio.
Current Value
$102.8M
Current Shares
4.9M
Total Value Change
+$32.6M
Total Shares Change
+1.4M
Quarter-by-Quarter History
Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P.